Frequent, high density expression of surface CD38 as a potential therapeutic target in adult T-lineage acute lymphoblastic leukemia
Sebastian Koslowski,
Rainer Glauben,
Stefan Habringer,
Thomas Burmeister,
Ulrich Keller,
Monika Brüggemann,
Nicola Gökbuget,
Stefan Schwartz
Affiliations
Sebastian Koslowski
Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin
Rainer Glauben
Department of Gastroenterology, Infectious Diseases and Rheumatology (Campus Benjamin Franklin), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin
Stefan Habringer
Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg
Thomas Burmeister
Department of Hematology, Oncology and Cancer Immunology (Campus Virchow-Klinikum), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin
Ulrich Keller
Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Max-Delbrück-Center, Berlin
Monika Brüggemann
University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel
Nicola Gökbuget
German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Medizinische Klinik II, Universitätsklinikum der Johann-Wolfgang-Goethe Universität, Frankfurt/Main
Stefan Schwartz
Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg
